268 related articles for article (PubMed ID: 19092631)
21. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions.
Anzick SL; Chen WD; Park Y; Meltzer P; Bell D; El-Naggar AK; Kaye FJ
Genes Chromosomes Cancer; 2010 Jan; 49(1):59-69. PubMed ID: 19827123
[TBL] [Abstract][Full Text] [Related]
22. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma.
Okumura Y; Miyabe S; Nakayama T; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
Histopathology; 2011 Jul; 59(1):90-7. PubMed ID: 21668476
[TBL] [Abstract][Full Text] [Related]
23. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.
Achcar Rde O; Nikiforova MN; Dacic S; Nicholson AG; Yousem SA
Hum Pathol; 2009 Jun; 40(6):854-60. PubMed ID: 19269006
[TBL] [Abstract][Full Text] [Related]
24. Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.
Birkeland AC; Foltin SK; Michmerhuizen NL; Hoesli RC; Rosko AJ; Byrd S; Yanik M; Nor JE; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
Oral Oncol; 2017 May; 68():5-8. PubMed ID: 28438292
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological significance of MAML2 gene split in mucoepidermoid carcinoma.
Noda H; Okumura Y; Nakayama T; Miyabe S; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
Cancer Sci; 2013 Jan; 104(1):85-92. PubMed ID: 23035786
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
[TBL] [Abstract][Full Text] [Related]
27. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.
Tirado Y; Williams MD; Hanna EY; Kaye FJ; Batsakis JG; El-Naggar AK
Genes Chromosomes Cancer; 2007 Jul; 46(7):708-15. PubMed ID: 17437281
[TBL] [Abstract][Full Text] [Related]
28. MAML2 Rearrangements in Variant Forms of Mucoepidermoid Carcinoma: Ancillary Diagnostic Testing for the Ciliated and Warthin-like Variants.
Bishop JA; Cowan ML; Shum CH; Westra WH
Am J Surg Pathol; 2018 Jan; 42(1):130-136. PubMed ID: 28877061
[TBL] [Abstract][Full Text] [Related]
29. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080
[TBL] [Abstract][Full Text] [Related]
30. MAML2 rearrangement in primary pulmonary mucoepidermoid carcinoma and the correlation with FLT1 expression.
Zhu F; Wang W; Hou Y; Shi J; Liu Z; He D; Bai C; Li S; Jiang L
PLoS One; 2014; 9(4):e94399. PubMed ID: 24714697
[TBL] [Abstract][Full Text] [Related]
31. A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma.
Fehr A; Meyer A; Heidorn K; Röser K; Löning T; Bullerdiek J
Genes Chromosomes Cancer; 2009 Sep; 48(9):777-85. PubMed ID: 19521953
[TBL] [Abstract][Full Text] [Related]
32. Mucoepidermoid carcinoma: a five-decade journey.
Chenevert J; Barnes LE; Chiosea SI
Virchows Arch; 2011 Feb; 458(2):133-40. PubMed ID: 21243374
[TBL] [Abstract][Full Text] [Related]
33. A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas.
Seethala RR; Dacic S; Cieply K; Kelly LM; Nikiforova MN
Am J Surg Pathol; 2010 Aug; 34(8):1106-21. PubMed ID: 20588178
[TBL] [Abstract][Full Text] [Related]
34. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene.
Behboudi A; Enlund F; Winnes M; Andrén Y; Nordkvist A; Leivo I; Flaberg E; Szekely L; Mäkitie A; Grenman R; Mark J; Stenman G
Genes Chromosomes Cancer; 2006 May; 45(5):470-81. PubMed ID: 16444749
[TBL] [Abstract][Full Text] [Related]
35. Spindle Cell Mucoepidermoid Carcinoma of the Palatine Tonsil With CRTC1-MAML2 Fusion Transcript: Report of a Rare Case in a 17-Year-Old Boy and a Review of the Literature.
Goh GH; Lim CM; Vanacek T; Michal M; Petersson F
Int J Surg Pathol; 2017 Dec; 25(8):705-710. PubMed ID: 28637362
[TBL] [Abstract][Full Text] [Related]
36. Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus.
Roden AC; Erickson-Johnson MR; Yi ES; García JJ
Hum Pathol; 2013 Dec; 44(12):2799-805. PubMed ID: 24134933
[TBL] [Abstract][Full Text] [Related]
37. Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma.
Jee KJ; Persson M; Heikinheimo K; Passador-Santos F; Aro K; Knuutila S; Odell EW; Mäkitie A; Sundelin K; Stenman G; Leivo I
Mod Pathol; 2013 Feb; 26(2):213-22. PubMed ID: 23018873
[TBL] [Abstract][Full Text] [Related]
38. Warthin-like Mucoepidermoid Carcinoma: A Combined Study of Fluorescence In Situ Hybridization and Whole-slide Imaging.
Ishibashi K; Ito Y; Masaki A; Fujii K; Beppu S; Sakakibara T; Takino H; Takase H; Ijichi K; Shimozato K; Inagaki H
Am J Surg Pathol; 2015 Nov; 39(11):1479-87. PubMed ID: 26457352
[TBL] [Abstract][Full Text] [Related]
39. A new type of MAML2 fusion in mucoepidermoid carcinoma.
Fehr A; Röser K; Heidorn K; Hallas C; Löning T; Bullerdiek J
Genes Chromosomes Cancer; 2008 Mar; 47(3):203-6. PubMed ID: 18050304
[TBL] [Abstract][Full Text] [Related]
40. Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.
Nakano S; Okumura Y; Murase T; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Kawakita D; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
Histopathology; 2022 Mar; 80(4):729-735. PubMed ID: 34657306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
